Silencing of the polyamine catabolic key enzyme SSAT prevents CDK inhibitor-induced apoptosis in Caco-2 colon cancer cells

Çoker,A.; Arısan,E. D.; Palavan-Ünsal,N.

doi:10.3892/mmr.2012.768

Silencing of the polyamine catabolic key enzyme SSAT prevents CDK inhibitor-induced apoptosis in Caco-2 colon cancer cells

Authors:
- A. Çoker
- E. D. Arısan
- N. Palavan-Ünsal
View Affiliations

Affiliations: Department of Molecular Biology and Genetics, Science and Literature Faculty, Istanbul Kultur University, Atakoy Campus, 34156 Istanbul, Turkey
Published online on: January 30, 2012 https://doi.org/10.3892/mmr.2012.768
Pages: 1037-1042

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Roscovitine and purvalanol are purine derivative cyclin-dependent kinase (CDK) inhibitors that induce apoptosis in various types of cancer cells. However, their impact on the apoptotic cell death mechanism requires further elucidation. Natural polyamines putrescine, spermidine and spermine play essential roles in the regulation of cell growth and proliferation. Increased levels of polyamines in cells are considered to be involved in cancer progression. Intracellular polyamine levels are under the control of several catabolic enzymes, such as spermidine/spermine-N-acetyl transferase (SSAT), acetylpolyamine oxidase (APAO) and spermine oxidase (SMO), which could be altered by several therapeutic drugs. However, the possible role of polyamines in drug-induced apoptosis has yet to be clarified. In the present study, our aim was to determine the modulation of the polyamine catabolic pathway related to CDK inhibitor-induced apoptosis in Caco-2 cells. We found that roscovitine and purvalanol (each 20 µM) induced apoptosis by activating caspase-9 and -3, and inhibiting the mitochondrial membrane potential in Caco-2 cells. CDK inhibitors decreased the intracellular putrescine and spermine levels without affecting spermidine levels. Although both roscovitine and purvalanol induced SSAT expression, they did not exert a significant effect on the APAO expression profile. SSAT transient silencing prevented roscovitine-induced apoptosis compared to parental cells. Thus, we concluded that roscovitine and purvalanol significantly induce apoptosis in Caco-2 cells by modulating the polyamine catabolism, and that SSAT could be an important target in evaluating the potential role of polyamines in apoptotic cell death.

View Figures

View References

1	S BlagdenJ de BonoDrugging cell cycle kinases in cancer therapyCurr Drug Targets6325335200510.2174/138945005376582415857291
2	KH ChangY de PabloHP LeeHG LeeMA SmithK ShahCdk5 is a major regulator of p38 cascade: relevance to neurotoxicity in Alzheimer's diseaseJ Neurochem11312211229201020345761
3	LM SchangAdvances on cyclin-dependent kinases (CDKs) as novel targets for antiviral drugsCurr Drug Targets Infect Disord52937200510.2174/156800505317460915777196
4	J CicenasM ValiusThe CDK inhibitors in cancer research and therapyJ Cancer Res Clin Oncol13714091418201110.1007/s00432-011-1039-421877198
5	H IsekiTC KoXY XueA SeapanMR HellmichCM Townsend JrCyclin-dependent kinase inhibitors block proliferation of human gastric cancer cellsSurgery122187195199710.1016/S0039-6060(97)90008-89288122
6	L MeijerA BorgneO MulnerBiochemical and cellular effects of roscovitine, a potent and selective inhibitor of the cyclin-dependent kinases cdc2, cdk2 and cdk5Eur J Biochem243527536199710.1111/j.1432-1033.1997.t01-2-00527.x
7	B SchutteL NielandM van EngelandME HenflingL MeijerFC RamaekersThe effect of the cyclin-dependent kinase inhibitor olomoucine on cell cycle kineticsExp Cell Res236415199710.1006/excr.1997.37009344580
8	J Wesierska-GadekSB HajekB SargS WandlE WalziH LindnerPleiotropic effects of selective CDK inhibitors on human normal and cancer cellsBiochem Pharmacol7615031514200810.1016/j.bcp.2008.07.04018761330
9	T David-PfeutyPotent inhibitors of cyclin-dependent kinase 2 induce nuclear accumulation of wild-type p53 and nucleolar fragmentation in human untransformed and tumor-derived cellsOncogene1874097422199910.1038/sj.onc.1203103
10	MV AppleyardMA O'NeillKE MurraySeliciclib (CYC202, R-roscovitine) enhances the antitumor effect of doxorubicin in vivo in a breast cancer xenograft modelInt J Cancer124465472200910.1002/ijc.2393819003963
11	G Ortiz-FerronR YerbesA EramoAI Lopez-PerezR de MariaA Lopez-RivasRoscovitine sensitizes breast cancer cells to TRAIL-induced apoptosis through a pleiotropic mechanismCell Res18664676200810.1038/cr.2008.54
12	J Wesierska-GadekMP KramerM MaurerResveratrol modulates roscovitine-mediated cell cycle arrest of human MCF-7 breast cancer cellsFood Chem Toxicol4613271333200810.1016/j.fct.2007.09.00417933449
13	F ZhangT ZhangZP GuEnhancement of radiosensitivity by roscovitine pretreatment in human non-small cell lung cancer A549 cellsJ Radiat Res (Tokyo)49541548200810.1269/jrr.0802418728343
14	S MohapatraB ChuX ZhaoJ DjeuJQ ChengWJ PledgerApoptosis of metastatic prostate cancer cells by a combination of cyclin-dependent kinase and AKT inhibitorsInt J Biochem Cell Biol41595602200910.1016/j.biocel.2008.07.01318708158
15	M MaurerO KominaJ Wesierska-GadekRoscovitine differentially affects asynchronously growing and synchronized human MCF-7 breast cancer cellsAnn NY Acad Sci1171250256200910.1111/j.1749-6632.2009.04717.x19723062
16	JD ZolnierczykJZ BlonskiT RobakZM KilianskaJ Wesierska-GadekRoscovitine triggers apoptosis in B-cell chronic lymphocytic leukemia cells with similar efficiency as combinations of conventional purine analogs with cyclophosphamideAnn NY Acad Sci1171124131200910.1111/j.1749-6632.2009.04903.x
17	D IizukaO InanamiI KashiwakuraM KuwabaraPurvalanol A enhances cell killing by inhibiting up-regulation of CDC2 kinase activity in tumor cells irradiated with high doses of X raysRadiat Res167563571200710.1667/RR0622.117474786
18	L CerquettiC SampaoliD AmendolaMitotane sensitizes adrenocortical cancer cells to ionizing radiations by involvement of the cyclin B1/CDK complex in G2 arrest and mismatch repair enzymes modulationInt J Oncol374935012010
19	T HikitaC OneyamaM OkadaPurvalanol A, a CDK inhibitor, effectively suppresses Src-mediated transformation by inhibiting both CDKs and c-SrcGenes Cells1510511062201010.1111/j.1365-2443.2010.01439.x20825494
20	PM PriceF YuP KaldisDependence of cisplatin-induced cell death in vitro and in vivo on cyclin-dependent kinase 2J Am Soc Nephrol1724342442200610.1681/ASN.200602016216914540
21	D IizukaA OguraM KuwabaraO InanamiPurvalanol A induces apoptosis and downregulation of antiapoptotic proteins through abrogation of phosphorylation of JAK2/STAT3 and RNA polymerase IIAnticancer Drugs19565572200810.1097/CAD.0b013e3282fe330e18525315
22	M PennatiAJ CampbellM CurtoPotentiation of paclitaxel-induced apoptosis by the novel cyclin-dependent kinase inhibitor NU6140: a possible role for survivin down-regulationMol Cancer Ther413281337200510.1158/1535-7163.MCT-05-002216170024
23	VM YenugondaTB DebSC GrindrodFluorescent cyclin-dependent kinase inhibitors block the proliferation of human breast cancer cellsBioorg Med Chem1927142725201110.1016/j.bmc.2011.02.05221440449
24	L RingerP SirajuddinVM YenugondaVMY-1–103, a dansylated analog of purvalanol B, induces caspase-3-dependent apoptosis in LNCaP prostate cancer cellsCancer Biol Ther103203252010
25	LJ MartonAE PeggPolyamines as targets for therapeutic interventionAnnu Rev Pharmacol Toxicol355591199510.1146/annurev.pa.35.040195.0004157598507
26	LJ MartonAE PeggDR MorrisDirections for polyamine researchJ Cell Biochem4578199110.1002/jcb.2404501052005186
27	G AnderssonO HebyKinetics of cell proliferation and polyamine synthesis during Ehrlich ascites tumor growthCancer Res37436143661977922727
28	O HebyG AnderssonJW GrayInterference with S and G2 phase progression by polyamine synthesis inhibitorsExp Cell Res111461464197810.1016/0014-4827(78)90192-1627248
29	U BachrachPolyamines as chemical markers of malignancyItal J Biochem2577931976773897
30	MG MontiL PerneccoR ManfrediniInhibition of cell growth by accumulated spermine is associated with a transient alteration of cell cycle progressionLife Sci5820652072199610.1016/0024-3205(96)00200-78649191
31	Y WangRA Casero JrMammalian polyamine catabolism: a therapeutic target, a pathological problem, or both?J Biochem1391725200610.1093/jb/mvj02116428315
32	RA CaseroAE PeggPolyamine catabolism and diseaseBiochem J421323338200910.1042/BJ2009059819589128
33	Y HuangA PledgieRA Casero JrNE DavidsonMolecular mechanisms of polyamine analogs in cancer cellsAnticancer Drugs16229241200510.1097/00001813-200503000-0000215711175
34	Y ChenRS WeeksMR BurnsDW BoormanA Klein-SzantoTG O'BrienCombination therapy with 2-difluoromethylornithine and a polyamine transport inhibitor against murine squamous cell carcinomaInt J Cancer11823442349200610.1002/ijc.2162116331620
35	MR BurnsGF GraminskiRS WeeksY ChenTG O'BrienLipophilic lysine-spermine conjugates are potent polyamine transport inhibitors for use in combination with a polyamine biosynthesis inhibitorJ Med Chem5219831993200910.1021/jm801580w
36	L MyhreK AlmC HegardtDifferent cell cycle kinetic effects of N1,N11-diethylnorspermine-induced polyamine depletion in four human breast cancer cell linesAnticancer Drugs19359368200810.1097/CAD.0b013e3282f7f51818454046
37	K DredgeJA KinkRM JohnsonI BythewayLJ MartonThe polyamine analog PG11047 potentiates the antitumor activity of cisplatin and bevacizumab in preclinical models of lung and prostate cancerCancer Chemother Pharmacol65191195200910.1007/s00280-009-1105-719685053
38	S HectorR TummalaND KisielPolyamine catabolism in colorectal cancer cells following treatment with oxaliplatin, 5-fluorouracil and N1, N11 diethylnorspermineCancer Chemother Pharmacol62517527200810.1007/s00280-007-0633-217987291
39	WL AllenEG McLeanJ BoyerThe role of spermidine/spermine N1-acetyltransferase in determining response to chemotherapeutic agents in colorectal cancer cellsMol Cancer Ther6128137200710.1158/1535-7163.MCT-06-030317237273
40	N BabbarEW GernerRA Casero JrInduction of spermidine/spermine N1-acetyltransferase (SSAT) by aspirin in Caco-2 colon cancer cellsBiochem J394317324200610.1042/BJ2005129816262603
41	ED ArisanA CokerN Palavan-UnsalPolyamine depletion enhances the roscovitine-induced apoptosis through the activation of mitochondria in HCT116 colon carcinoma cellsAmino AcidsAug22011(E-pub ahead of print).
42	OM TiradoS Mateo-LozanoV NotarioRoscovitine is an effective inducer of apoptosis of Ewing's sarcoma family tumor cells in vitro and in vivoCancer Res6593209327200510.1158/0008-5472.CAN-05-127616230394
43	R VarmaS HectorWR GrecoPlatinum drug effects on the expression of genes in the polyamine pathway: time-course and concentration-effect analysis based on Affymetrix gene expression profiling of A2780 ovarian carcinoma cellsCancer Chemother Pharmacol59711723200710.1007/s00280-006-0325-317021820
44	A PledgieY HuangA HackerSpermine oxidase SMO(PAOh1), not N1-acetylpolyamine oxidase PAO, is the primary source of cytotoxic H₂O₂ in polyamine analogue-treated human breast cancer cell linesJ Biol Chem2803984339851200516207710